Iryna Lebedyeva

Prof. Iryna Lebedyeva


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2018 in Neoplasia
Verified
Journal Article
Open access
KAKartik Angara
Kartik Angara
TBThaiz Borin
Thaiz Borin
Mohammad Harun RashidMohammad Harun Rashid
Mohammad Harun Rashid
ILIryna Lebedyeva
Iryna Lebedyeva
RARoxan Ara
Roxan Ara
AAAli S. Arbab
Ali S. Arbab
Glioblastoma (GBM) was shown to relapse faster and displayed therapeutic resistance to antiangiogenic therapies (AATs) through an alternative tumor cell-driven mechanism of neovascularization called vascular mimicry (VM). We identified highly upregulated interleukin 8 (IL-8)-CXCR2 axis in tumor cells in high-grade human glioma and AAT-treated orthotopic GBM tumors. Human GBM tissue sections and tissue array were used to ascertain the clinical relevance of CXCR2-positive tumor cells in the formation of VM. We utilized U251 and U87 human tumor cells to understand VM in an orthotopic GBM model and AAT-mediated enhancement in VM was modeled using vatalanib (anti-VEGFR2) and avastin (anti-VEGF). Later, VM was inhibited by SB225002 (CXCR2 inhibitor) in a preclinical study. Overexpression of IL8 and CXCR2 in human datasets and histological analysis was identified as a bonafide candidate to validate VM through in vitro and animal model studies. AAT-treated tumors displayed a higher number of CXCR2-positive GBM-stem cells with endothelial-like phenotypes. Stable knockdown of CXCR2 expression in tumor cells led to decreased tumor growth as well as incomplete VM structures in the animal models. Similar data were obtained following SB225002 treatment. The present study suggests that tumor cell autonomous IL-8-CXCR2 pathway is instrumental in AAT-mediated resistance and VM formation in GBM. Therefore, CXCR2 can be targeted through SB225002 and can be combined with standard therapies to improve the therapeutic outcomes in clinical trials.

4 August 2016 in Scientific Reports
Verified
Journal Article
Open access
GCGenevieve L. Coe
Genevieve L. Coe
PRPriscilla S. Redd
Priscilla S. Redd
APAmy V. Paschall
Amy V. Paschall
CLChunwan Lu
Chunwan Lu
LGLilly Gu
Lilly Gu
KLKebin Liu
Kebin Liu
FasL-mediated cytotoxicity is one of the mechanisms that CTLs use to kill tumor cells. However, human colon carcinoma often deregulates the Fas signaling pathway to evade host cancer immune surveillance. We aimed at testing the hypothesis that novel ceramide analogs effectively modulate Fas function to sensitize colon carcinoma cells to FasL-induced apoptosis. We used rational design and synthesized twenty ceramide analogs as Fas function modulators. Five ceramide analogs, IG4, IG7, IG14, IG17, and IG19, exhibit low toxicity and potent activity in sensitization of human colon carcinoma cells to FasL-induced apoptosis. Functional deficiency of Fas limits both FasL and ceramide analogs in the induction of apoptosis. Ceramide enhances FasL-induced activation of the MAPK, NF-κB, and caspase 8 despite induction of potent tumor cell death. Finally, a sublethal dose of several ceramide analogs significantly increased CTL-mediated and FasL-induced apoptosis of colon carcinoma cells. We have therefore developed five novel ceramide analogs that act at a sublethal dose to enhance the efficacy of tumor-specific CTLs, and these ceramide analogs hold great promise for further development as adjunct agents in CTL-based colon cancer immunotherapy.

12 February 2021 in Molecules
Verified
Journal Article
Open access
PDF file
John NeubertJohn Neubert
John Neubert
AOAlexander A. Oliferenko
Alexander A. Oliferenko
POPolina V. Oliferenko
Polina V. Oliferenko
SESergey V. Emets
Sergey V. Emets
DODavid Ostrov
David Ostrov
ILIryna Lebedyeva
Iryna Lebedyeva
Local anesthetics are widely utilized in dentistry, cosmetology, and medicine. Local anesthesia is essential to providing a pain-free experience during dental and local surgeries as well as cosmetic procedures. However, the injection itself may produce discomfort and be a source of aversion. A novel approach toward the taste modulation of local anesthetics is proposed, in which the anesthetics of the “-caine” family serve as cations and are coupled with anionic sweeteners such as saccharinate and acesulfamate. Ionic conjugates of vasoconstrictor epinephrine such as epinephrine saccharinate and epinephrine acesulfamate have also been synthesized. Novel ionic conjugates were developed using anion exchange techniques. Reported compounds are sweet-tasting and are safe to use both topically and as injections.

12 November 2017 in Journal of Heterocyclic Chemistry
Verified
Journal Article
Closed access
PDF file
PLPavel P. Lyubashov
Pavel P. Lyubashov
VPVyacheslav M. Povstyanoy
Vyacheslav M. Povstyanoy
AKAndrey A. Krysko
Andrey A. Krysko
APAlexander Plotkin
Alexander Plotkin
ILIlene Lovett
Ilene Lovett
ILIryna Lebedyeva
Iryna Lebedyeva

4 February 2020 in bioRxiv
Verified
Preprint
Open access
PDF file
SASehar Ali
Sehar Ali
TBThaiz Borin
Thaiz Borin
RPRaziye Piranlioglu
Raziye Piranlioglu
RARoxan Ara
Roxan Ara
ILIryna Lebedyeva
Iryna Lebedyeva
Mohammad Harun RashidMohammad Harun Rashid
Mohammad Harun Rashid
Glioblastoma (GBM) is a hypervascular and aggressive primary malignant tumor of the central nervous system. Recent investigations showed that traditional therapies along with antiangiogenic therapies failed due to the development of post-therapy resistant and recurrent GBM. Our investigations show that there are changes in the cellular and metabolic compositions in the tumor microenvironment (TME). It can be said that tumor cell-directed therapies are ineffective and we need to rethink how to treat GBM.We hypothesize that the composition of TME-associated cells will be different based on the therapy and therapeutic agents, and TME-targeting therapy will be better to decrease recurrence and improve survival. Therefore, the purpose of this study is to determine the changes in the TME in respect of T-cell population, M1 and M2 macrophage polarization status, and MDSC population following different treatments in a syngeneic model of GBM. In addition to these parameters, tumor growth and survival were also studied following different treatments.The results showed that changes in the TME-associated cells were dependent on the therapeutic agents and the TME-targeting therapy improved the survival of the GBM bearing animals.The current GBM therapies should be revisited to add agents to prevent the accumulation of bone marrow-derived cells in the TME or to prevent the effect of immune-suppressive myeloid cells in causing alternative neovascularization, the revival of glioma stem cells, and recurrence. Instead of concurrent therapy, a sequential strategy would be best to target TME-associated cells.

9 January 2018 in Acta Crystallographica Section E Crystallographic Communications
Verified
Journal Article
Open access
PDF file
YYYegor Yartsev
Yegor Yartsev
PLPavel Lyubashov
Pavel Lyubashov
VPVyacheslav Povstyanoy
Vyacheslav Povstyanoy
MPMykhailo Povstyaniy
Mykhailo Povstyaniy
ILIryna Lebedyeva
Iryna Lebedyeva
The title compound, C24H18N2O4S, crystallizes in the orthorhombic P212121 space group, indicating the existence of only one enantiomer with an S configuration of the chiral center in the crystal phase. The dihydropyrimidine ring adopts a twist-boat conformation while the quinone ring is slightly non-planar. In the crystal, molecules are linked by weak C—H...O and C—H...S hydrogen bonds and C—H...π interactions. In addition, a short intermolecular S...N contact of 3.250 (3) Å indicates an interaction between the S atom and the π-system of the thiazole ring.